BioSpace News Archive

Global health service company Cigna Corporation will release its first quarter 2021 financial results on Friday, May 7, 2021, and will host a conference call the same day.

The Foundation for the National Institutes of Health has named Xiaowei Zhuang, Ph.D., winner of the 2021 Lurie Prize in Biomedical Sciences for pioneering the development of super-resolution microscopy and genome-scale imaging showing new spatial and functional organizations of molecules and cells.

Viome, a mission-driven systems biology company aiming to help individuals improve their health, today announced the appointment of Dr. Emmanuel Hanon as Global Head of Research and Development (R&D)

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the B. Riley Securities’ Neuroscience Conference, April 28-29, 2021.

Anji Pharma has initiated dosing in the U.S. and China as part of a Phase 2 program for pradigastat (ANJ908) in functional constipation. Pradigastat, a first-in-class inhibitor of diacylglycerol acyl transferase 1 (DGAT1), has a robust safety and pharmacodynamic profile that has been rigorously established across multiple clinical studies.

Limitless Venture Group, Inc. reported RECORD REVENUES for their new fiscal year 2020, which now matches the Calendar Year and that of its subsidiaries, of $539,230 as compared to $54,206 for their last fiscal year 2019, adjusted to match the calendar year.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced two posters will be presented at the American Academy of Neurology (AAN) 73rd Annual Meeting

To help accelerate innovation in Canada’s biotechnology industry, BIOTECanada and Cognit.ca are partnering to launch the Biotechnology R&D Portal and the Biotechnology R&D Showcase webinar series.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has announced the publication of a clinical study on Kemin Human Nutrition and Health’s DailyZz™ sleep ingredient.

Parexel and Veeva Systems (NYSE: VEEV) today announced a strategic collaboration to accelerate clinical trials through technology and process innovation.